InvestorsHub Logo
Followers 21
Posts 3214
Boards Moderated 0
Alias Born 07/03/2020

Re: Aceinhibitor561 post# 43931

Sunday, 03/07/2021 12:36:35 PM

Sunday, March 07, 2021 12:36:35 PM

Post# of 52604
Israeli company with a sleep apnea bracelet wants entry into the US market through APYP R/M. The merging company already introduced the technology in Israel and achieved an 8% market share there in a short period of time. So once we have merger in place with APYP we could see into late FY21 /FY22 a sizeable new business /sales in these devices which are much less intrusive than standard CPAP machines used mostly today.

I did some prelim calculations below....but still very early just at the LOI stage and developing; however, $.06 is probably conservative since I only included US market for Men and only 8% penetration of that population that could benefit. The company has actually talked about international expansion as well into Europe..and a sizeable % of female population could also buy

5,200,000 8% of adult men >=40 years of age in the US buying (57% est to have snoring or sleep apnea)
$89 Net Price to APYP /Device with 40% Discount for distribution and marketing
5,200,000 # of devices sold in 5 years
$464,880,000 Revenue in 5 years
92,976,000 Revenue per year (approx 7.8M per month)
371,904,000 Market Cap 4X Annual Revenue
6,000,000,000 Shares
$0.06 Target price per share
0.0026 Curr price @3/7/2021
24 Bagger
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent APYP News